So what is critically lacking with coronary atherosclerotic plaques? Perhaps the antithrombotic control.
Edgington
T S
TS
Departments of Vascular Biology and Immunology, The Scripps Research Institute, La Jolla, California 92037, USA. tse@scripps.edu
D003324:Coronary Artery Disease / Q000150:complications* / Q000503:physiopathology*; D003328:Coronary Thrombosis / Q000209:etiology*; D006801:Humans